What’s Your Biggest CTIS Challenge?— Share Your Insights!
Cromos Pharma
![Cromos Pharma]()
Cromos Pharma
US-based international CRO helping clients develop drugs and treatments that save and improve the lives of patients
While the EU’s CTIS platform is intended to streamline submissions, many sponsors still face practical hurdles — from navigating the system and managing country-specific documents to responding to RFIs under pressure.
At Cromos Pharma, we've supported numerous CTIS submissions and are now building a webinar packed with actionable resources: ready-to-use tools, real case studies, and live Q&A with experts.
Before we finalize the content, we want to hear from you. What’s been the toughest part of working with CTIS?
Take our short 3-minute survey (personal details are optional—share only what you're comfortable with)
https://forms.office.com/e/iS2CQJPj93.
As a thank-you, you’ll receive early access to register and help shape a session tailored to real-world challenges.
Chief Business Development Officer at Cromos Pharma
4moLooking forward to this! CTIS has improved, but multi-country submissions are still a real pain point.
Associate Business Development Director, Europe at Cromos Pharma
4moThis is a great initiative. CTIS still raises a lot of questions—happy to contribute!